Drugs / GlyT-1 inhibitor-1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01251055 | Apr 2010 → Oct 2013 | treatment-refractory schizophrenia | China Medical University Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GlyT-1 inhibitor-1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01251055 ↗ |
| Action | Inhibit | “glycine transporter(GlyT)-1 inhibitor adjuvant therapy” NCT01251055 ↗ |